Literature DB >> 9875680

Pharmacokinetic interactions between acute alcohol ingestion and single doses of benzodiazepines, and tricyclic and tetracyclic antidepressants -- an update.

E Tanaka1, S Misawa.   

Abstract

Recent reports of interactions between alcohol and benzodiazepines, tricyclic and tetracyclic antidepressants during their acute concomitant use are reviewed. Acute ingestion of alcohol (ethanol) with tranquilizers or hypnotics is responsible for several pharmacokinetic interactions that can have significant clinical implications. In general, metabolism of these drugs is delayed when combined with alcohol but some reports have suggested otherwise. The amount of alcohol consumed, the presence or absence of liver disease, and differences in the dosage and administration of these drugs may account for the observed discrepancies. In recent years, the cytochrome P450 (P450 or CYP) isoenzyme that catalyses the metabolism of these drugs has also been identified. However, since changes in the pharmacogenetic metabolism of benzodiazepines and tricyclic and tetracyclic antidepressants are mainly governed by CYP2C19 and CYP2D6, caution is needed when used together with alcohol.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9875680     DOI: 10.1046/j.1365-2710.1998.00175.x

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  3 in total

1.  Modulatory influence of noscapine on the ethanol-altered hepatic biotransformation system enzymes, glutathione content and lipid peroxidation in vivo in rats.

Authors:  Ritu Aneja; Anju Katyal; Ramesh Chandra
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2004 Jul-Sep       Impact factor: 2.441

2.  Effect of variations in treatment regimen and liver cirrhosis on exposure to benzodiazepines during treatment of alcohol withdrawal syndrome.

Authors:  Pavel Gershkovich; Kishor M Wasan; Charles Ribeyre; Fady Ibrahim; John H McNeill
Journal:  Drugs Context       Date:  2015-08-07

3.  Remimazolam Has Low Oral Bioavailability and No Potential for Misuse in Drug-Facilitated Sexual Assaults, with or Without Alcohol: Results from Two Randomised Clinical Trials.

Authors:  Marija Pesic; Thomas Stöhr; Joachim Ossig; Keith Borkett; Martin Donsbach; Van-Anh Dao; Lynn Webster; Frank Schippers
Journal:  Drugs R D       Date:  2020-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.